TITLE

The classics in perspective

AUTHOR(S)
Panés, Julián; Ghosh, Subrata
PUB. DATE
September 2007
SOURCE
Gut;Sep2007, Vol. 56 Issue 9, p1184
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The authors reflect on the development of anti-cytokine therapies as biological agents in treating Crohn's disease and inflammatory diseases. Their therapeutic approach to these diseases has expanded. They noted that gastroenterologists face a remarkable wave of new biological therapies for inflammatory bowel diseases (IBD) including anti-tumor necrosis factor. They noted that the efficacy of adalimumab for induction of remission in patients with active Crohn's disease.
ACCESSION #
26437220

 

Related Articles

  • Cytokine Therapies in Crohn's Disease: Where are We Now and where should We Go? Caprioli, Flavio; Pallone, Francesco; Monteleone, Giovanni // Inflammation & Allergy - Drug Targets;Feb2011, Vol. 10 Issue 1, p47 

    No abstract available.

  • Prohibitin 1 Modulates Mitochondrial Stress-Related Autophagy in Human Colonic Epithelial Cells. Kathiria, Arwa S.; Butcher, Lindsay D.; Feagins, Linda A.; Souza, Rhonda F.; Boland, C. Richard; Theiss, Arianne L. // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    Introduction: Autophagy is an adaptive response to extracellular and intracellular stress by which cytoplasmic components and organelles, including damaged mitochondria, are degraded to promote cell survival and restore cell homeostasis. Certain genes involved in autophagy confer susceptibility...

  • The Role Of T Helper Cytokines In Indeterminate Colitis. Mahdi, Batool Mutar // National Journal of Integrated Research in Medicine;2011, Vol. 2 Issue 1, p1 

    Background: Indeterminate colitis is one of the inflammatory bowel diseases that cannot be classified over time as having ulcerative colitis or Crohn's disease. Dysregulated immunity has been implicated in indeterminate colitis.Aim: to measure serum levels of pro-inflammatory cytokines (tumor...

  • Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial. Sandborn, W. J.; Hanauer, S. B.; Rutgeerts, P.; Fedorak, R. N.; Lukas, M.; MacIntosh, D. G.; Panaccione, R.; Wolf, D.; Kent, J. D.; Bittle, B.; Li, J.; Pollack, P. F. // Gut;Sep2007, Vol. 56 Issue 9, p1232 

    Background: Adalimumab induced clinical remission after four weeks in patients with active Crohn's disease in the CLASSIC I trial. Objective: To evaluate long term efficacy and safety of adalimumab maintenance therapy in Crohn's disease in a follow-on randomised controlled trial (CLASSIC II)....

  • Recent Approaches in Pathogenesis of Inflammatory Bowel Disease. Solanki, Roshni; Madat, Dhaval; Chauhan, Khushbu; Parmar, Lalkrushn // International Journal of PharmTech Research;Jul-Sep2010, Vol. 2 Issue 3, p1796 

    Inflammatory bowel disease (IBD) commonly refers to ulcerative colitis (UC) and Crohn disease (CD), which are chronic inflammatory diseases of the GI tract of unknown etiology. This inflammatory response is most likely made possible by defects in both the mucosal immune system and the barrier...

  • Congenital Hydrocephalus and Abnormal Subcommissural Organ Development in Sox3 Transgenic Mice. Lee, Kristie; Tan, Jacqueline; Morris, Michael B.; Rizzoti, Karine; Hughes, James; Cheah, Pike See; Felquer, Fernando; Liu, Xuan; Piltz, Sandra; Lovell-Badge, Robin; Thomas, Paul Q. // PLoS ONE;Jan2012, Vol. 7 Issue 1, p1 

    Congenital hydrocephalus (CH) is a life-threatening medical condition in which excessive accumulation of CSF leads to ventricular expansion and increased intracranial pressure. Stenosis (blockage) of the Sylvian aqueduct (Aq; the narrow passageway that connects the third and fourth ventricles)...

  • Prohibitin 1 Modulates Mitochondrial Stress-Related Autophagy in Human Colonic Epithelial Cells. Kathiria, Arwa S.; Butcher, Lindsay D.; Feagins, Linda A.; Souza, Rhonda F.; Boland, C. Richard; Theiss, Arianne L. // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    Introduction: Autophagy is an adaptive response to extracellular and intracellular stress by which cytoplasmic components and organelles, including damaged mitochondria, are degraded to promote cell survival and restore cell homeostasis. Certain genes involved in autophagy confer susceptibility...

  • TNFα inhibitor induced lupus-like syndrome (TAILS) in a patient with IBD. LUPU, A.; TIERANU, C.; CONSTANTINESCU, C. L.; DICULESCU, M. // Current Health Sciences Journal;2014, Vol. 40 Issue 4, p285 

    Background: In patients with autoimmune diseases like inflammatory bowel diseases there has been reported a drug-induced lupus like syndrome secondary to TNFα inhibitors. Objective: clinical case presentation and literature review of patients who develop lupus-like syndrome in relation to...

  • Targeted resequencing identifies defective variants of decoy receptor 3 in pediatric-onset inflammatory bowel disease. Cardinale, C J; Wei, Z; Panossian, S; Wang, F; Kim, C E; Mentch, F D; Chiavacci, R M; Kachelries, K E; Pandey, R; Grant, S F A; Baldassano, R N; Hakonarson, H // Genes & Immunity;Oct/Nov2013, Vol. 14 Issue 7, p447 

    Genome-wide association studies have implicated common variation at the 20q13 locus in inflammatory bowel disease, particularly for the pediatric Crohn's form. This locus harbors tumor necrosis factor receptor superfamily (TNFRSF6B), encoding a secreted protein, decoy receptor 3 (DcR3), which...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics